[Retracted] Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

Table 3

Comparison of myocardial enzymes before and after treatment (n, ± s).

Index	Time	Control group (n = 35)	Observation group (n = 35)	t value	P value
CK (U/L)	Before therapy	269.59 ± 65.17	267.17 ± 64.21	0.156	0.876
	After treatment	152.31 ± 16.72	90.81 ± 9.76	18.793	≤0.001
CK-MB (U/L)	Before therapy	55.83 ± 6.88	56.67 ± 6.25	0.535	0.595
	After treatment	27.06 ± 3.47	12.82 ± 1.22	22.904	≤0.001
cTnI (ug/L)	Before therapy	0.18 ± 0.03	0.17 ± 0.02	1.641	0.106
	After treatment	0.07 ± 0.02	0.02 ± 0.01	15.875	≤0.001

Note. Compared with the same group before treatment, .